Sanofi pumps up its Pompe portfolio with Maze deal | Evaluate
Sanofi Italia on X: "La nostra ricerca sulle malattie rare non si ferma: sono 39 le presentazioni che terremo in questi giorni al @WORLDSymposia 2022 a San Francisco. Tra queste, anche nuovi
Sanofi strengthens in Pompe disease with Maze tie-up
Sanofi Finds Way to Maze Therapeutics to Get Its Next Pompe Disease Drug - MedCity News
Malattie rare, le tre 'direzioni' dell'impegno di Sanofi - Osservatorio Malattie Rare
MeetSanofi | Malattia di Pompe, la qualità della vita passa anche dal cibo e dalla tecnologia
Lumizyme | The Pompe Registry
Sanofi Launched Advanced Treatment for Pompe Disease | CCI France Taiwan
Sanofi Deepens Pompe Disease Focus with $150M Maze Partnership | BioSpace
Sanofi posts 'better than expected' Q2 results, analysts say
Sanofi US on X: "Have you heard of #Pompe disease? Just knowing the symptoms of this #RareDisease could help reduce the time to diagnosis. Share with the hashtag #GreaterThanPompe to raise awareness
Sanofi Genzyme: The Compelling Evidence of Pompe - Stand Up, Reach Up, Give Up • Ads of the World™ | Part of The Clio Network
Sanofi Genzyme: COMET Phase 3 Trial - Results | Pompe Support Network
Sanofi on LinkedIn: #pompe | 20 comments
Sanofi termina l'accordo sulla licenza del farmaco dopo le obiezioni della FTC statunitense -11 dicembre 2023 alle 22:33 | MarketScreener
Sanofi Genzyme goes to Phase III with Neuromuscular Disease
MeetSanofi | Malattia di Pompe, la qualità della vita passa anche dal cibo e dalla tecnologia
Sanofi's drugs to treat Pompe disease and Niemann-Pick disease to be available in India soon- The New Indian Express
Sanofi to enter Maze deal with $750M pact for Pompe med
Sanofi Genzyme: The Compelling Evidence of Pompe - Stand Up, Reach Up, Give Up • Ads of the World™ | Part of The Clio Network
Sanofi extends its Pompe range with first Nexviazyme OK | pharmaphorum
Sanofi terminates deal to exclusively license Maze Therapeutics Pompe disease drug
International Pompe Day 2019 – Ricette per stare meglio – Associazione Italiana Glicogenosi
European Commission Approves Sanofi Enzyme Replacement Therapy for Pompe Disease - Global Genes
Sanofi win GOLD standard for the 'Patient Partnership Index'…with a little help from Pompe Support Network! | Pompe Support Network
